Abiopharma

New Form 8-K - Evofem Biosciences, Inc. Filed: 2025-07-02 AccNo: 0001641172-25-017563 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits